Cash & equivalents decreased 36.2%
Cash & equivalents changed -36.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$78.8M→$50.3M3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -36.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed -93.5% from the comparable as-filed period.
Net income changed -173.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.